GlassScriptPhysician profile
Matthew Carbary
NPI 1578298733
$11,925.06
in general payments reported to CMS, 2019-2025
36 companies · $1,047 in 2025
The $1,047 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,207 · 2023: $5,114 · 2024: $4,557 · 2025: $1,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,358 · Travel and Lodging: $1,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,358.10 |
| Travel and Lodging | $1,359.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $2,123.35 | 2022-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $1,815.44 | 2022-2025 | Nayzilam, Fintepla, Briviact |
| Abbvie INC. | $1,725.06 | 2022-2025 | |
| Mdd US Operations, LLC | $1,207.87 | 2023-2025 | Gocovri, Apokyn, Gocovri |
| Lundbeck LLC | $601.19 | 2022-2025 | Vyepti |
| Sk Life Science, INC. | $587.08 | 2022-2024 | Xcopri |
| Impel Pharmaceuticals INC. | $399.61 | 2022-2023 | Trudhesa |
| Neurelis, INC. | $398.55 | 2023-2024 | Valtoco |
| Lilly USA, LLC | $377.00 | 2022-2025 | Emgality, Reyvow |
| Pfizer INC. | $352.09 | 2023-2025 | |
| Tonix Medicines, INC. | $306.13 | 2024-2025 | Zembrace Symtouch |
| Otsuka America Pharmaceutical, INC. | $279.41 | 2023-2024 | Nuedexta |
| Amgen INC. | $267.47 | 2022-2023 | Aimovig |
| Teva Pharmaceuticals USA, INC. | $226.95 | 2022-2024 | Ajovy, Austedo Xr |
| Jazz Pharmaceuticals INC. | $200.47 | 2022-2025 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Carbary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.